aqueous gel

Aqueous gel is a topical water-based formulation commonly used as a pharmaceutical vehicle and emollient to hydrate the skin. In the context of DermBiont, Inc.'s clinical program for atopic dermatitis, this gel was utilized as the control (placebo) intervention in a Phase 2 randomized, observer-blinded, within-patient bilateral trial. The study was designed to evaluate the safety and efficacy of DBI-001—a live biotherapeutic product containing the bacterial strain *Janthinobacterium lividum*—by comparing it against the daily application of this aqueous gel vehicle over a four-week period. While the gel itself provides moisturizing benefits to the skin barrier, it lacks the active biological component targeted at the skin microbiome dysbiosis associated with atopic dermatitis.

Other names

vehicle gel